# New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

Page: https://stenobird.com/podcast/jama-medical-news-779603/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions
Text version: https://stenobird.com/podcast/jama-medical-news-779603/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions.md
Podcast: [JAMA Medical News](https://stenobird.com/podcast/jama-medical-news-779603)
Published: 2026-06-18T15:00:00+00:00
Episode link: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.7593
Audio file: https://traffic.libsyn.com/secure/jamamedicalnews/New_GLP-1_Drug_Options_and_More_Highlights_From_the_ADAs_2026_Scientific_Sessions_1.mp3?dest-id=525944
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions
Duration seconds: 1369

## Resource

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/jama-medical-news-779603/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.